Edgewise Therapeutics,  —

Recent Posts

• RNA-based approach shows promise for DM1 in cell models
• An emergency preparedness plan is crucial for those with disabilities
• Gene therapy at low dose helps two OPMD patients with swallowing
• Every week, we try to organize chaos in our family of 9
• Capricor now seeking FDA approval of DMD therapy deramiocel
• C-Path to lead new task force seeking to advance LGMD therapies
• Educating all ages about living with muscular dystrophy
• This time, new medical equipment is hard for me to accept
• Rare pediatric disease designation granted to LAMA2-CMD therapy
• DMD treatment WVE-N531 boosts dystrophin: Interim trial data